Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus

Jie LuoDepartment of Clinical Laboratory, Institute of Surgery Research, Daping Hospital, The Third Military Medical University, Chongqing, China and

Xiaochang NiuDepartment of Microbiology and Immunology, Chongqing Three Gorges Central Hospital, Chongqing, China

Mingxu ZhangDepartment of Clinical Laboratory, Institute of Surgery Research, Daping Hospital, The Third Military Medical University, Chongqing, China and

Kejun ZhangDepartment of Clinical Laboratory, Institute of Surgery Research, Daping Hospital, The Third Military Medical University, Chongqing, China and

Ming ChenDepartment of Clinical Laboratory, Institute of Surgery Research, Daping Hospital, The Third Military Medical University, Chongqing, China and Correspondence[email protected] [email protected]

Shaoli DengDepartment of Clinical Laboratory, Institute of Surgery Research, Daping Hospital, The Third Military Medical University, Chongqing, China and Correspondence[email protected] [email protected]

Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date